Optical Genome Mapping Market to Cross $1150.73 Mn by 2034
Optical Genome Mapping (OGM) is advancing diagnostics for hematological malignancies and genetic diseases with its ability to detect complex genetic variations quickly and affordably. Highlighted at ASH 2024, its role in cancer research grows. AI integration further enhances genomics by analyzing vast data efficiently.
Last Updated : 21 April 2026
Category: Biotechnology
Insight Code: 5384
Format: PDF / PPT / Excel